Coronary angiographic changes in patients with cardiac events in the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)
- 1 October 2002
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (7) , 776-778
- https://doi.org/10.1016/s0002-9149(02)02611-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Angiographic progression of coronary artery disease and the development of myocardial infarctionPublished by Elsevier ,2004
- Effect of Amlodipine on the Progression of Atherosclerosis and the Occurrence of Clinical EventsCirculation, 2000
- Process of Progression of Coronary Artery Lesions From Mild or Moderate Stenosis to Moderate or Severe StenosisCirculation, 1999
- Rationale, design, and baseline characteristics of the Prospective Randomized Evaluation of the Vascular Effects of Norvasc Trial (PREVENT)The American Journal of Cardiology, 1997
- Coronary Plaque DisruptionCirculation, 1995
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three timesAmerican Heart Journal, 1989
- Clinical and Angiographic Factors Associated With Coronary Artery Disease Progression of Coronary Artery DiseaseJournal of the American College of Cardiology, 1984